Doxycycline Recall: Hyclate 100 mg tablets
Announced 2026-05-13 · FDA
FDA recall notice for Doxycycline Hyclate Tablets, USP 100 mg, 500-count Rx bottles distributed nationwide by Acella Pharmaceuticals, LLC (NDC 42192-501-05). The recall is due to failed dissolution specifications found in stability testing for Lot P24ZLK1 (exp 5/31/2027). About 4,680 bottles are affected.
| Brand | Acella Pharmaceuticals, LLC |
|---|---|
| Product | Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05. |
| Reason | Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications. |
| Severity | moderate |
| Units affected | 6336 |
| Distribution | Nationwide in the USA |
| Agency | FDA |
WHAT YOU SHOULD DO
- Check if you have Doxycycline Hyclate 100 mg tablets from Acella with Lot P24ZLK1; verify the lot and expiration.
- If your bottle is affected, stop using it and contact your healthcare provider or pharmacist for guidance.
- Return or dispose of the product according to FDA recall instructions or your pharmacy's guidance.
- If you have questions, contact Acella Pharmaceuticals, LLC or the FDA recall information line.
How to identify the recalled item
| Lot / date codes | Lot #: P24ZLK1, Exp 5/31/2027 |
|---|---|
| Lot / date codes | Lot: 23F02, Expires: 05/2026; 25A37, Expires: 01/2028. |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.